Unexpected pancytopenia: Dasatinib induced aplastic anemia in chronic myeloid leukemia.

Prior reports have shown that aplasia/aplastic anemia can rarely be associated with imatinib and nilotinib. Here we show that dasatinib can lead to this phenomenon as well. This diagnosis should be considered in patients with CML who unexpectedly develop cytopenias.